<?xml version="1.0"?>
<?xml-stylesheet type="text/xsl" href="billres.xsl"?>
<!DOCTYPE bill PUBLIC "-//US Congress//DTDs/bill.dtd//EN" "bill.dtd">
<bill bill-stage="Introduced-in-House" bill-type="olc" dms-id="H6F3EB69AA5F44E7580A187EF67A98AA7" public-private="public">
	<metadata xmlns:dc="http://purl.org/dc/elements/1.1/">
<dublinCore>
<dc:title>114 HR 842 IH: Huntington’s Disease Parity Act of 2015</dc:title>
<dc:publisher>U.S. House of Representatives</dc:publisher>
<dc:date>2015-02-10</dc:date>
<dc:format>text/xml</dc:format>
<dc:language>EN</dc:language>
<dc:rights>Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.</dc:rights>
</dublinCore>
</metadata>
<form>
		<distribution-code display="yes">I</distribution-code>
		<congress>114th CONGRESS</congress>
		<session>1st Session</session>
		<legis-num>H. R. 842</legis-num>
		<current-chamber>IN THE HOUSE OF REPRESENTATIVES</current-chamber>
		<action>
			<action-date date="20150210">February 10, 2015</action-date>
			<action-desc><sponsor name-id="K000378">Mr. Kinzinger of Illinois</sponsor> (for himself, <cosponsor name-id="P000096">Mr. Pascrell</cosponsor>, <cosponsor name-id="S000250">Mr. Sessions</cosponsor>, <cosponsor name-id="S000480">Ms. Slaughter</cosponsor>, <cosponsor name-id="R000395">Mr. Rogers of Kentucky</cosponsor>, <cosponsor name-id="L000480">Mrs. Lowey</cosponsor>, <cosponsor name-id="J000290">Ms. Jenkins of Kansas</cosponsor>, <cosponsor name-id="V000128">Mr. Van Hollen</cosponsor>, <cosponsor name-id="D000216">Ms. DeLauro</cosponsor>, <cosponsor name-id="K000376">Mr. Kelly of Pennsylvania</cosponsor>, <cosponsor name-id="B000574">Mr. Blumenauer</cosponsor>, <cosponsor name-id="K000188">Mr. Kind</cosponsor>, <cosponsor name-id="T000460">Mr. Thompson of California</cosponsor>, <cosponsor name-id="L000557">Mr. Larson of Connecticut</cosponsor>, <cosponsor name-id="C001038">Mr. Crowley</cosponsor>, <cosponsor name-id="L000287">Mr. Lewis</cosponsor>, <cosponsor name-id="R000053">Mr. Rangel</cosponsor>, <cosponsor name-id="S001156">Ms. Linda T. Sánchez of California</cosponsor>, <cosponsor name-id="B001243">Mrs. Blackburn</cosponsor>, <cosponsor name-id="L000567">Mr. Lance</cosponsor>, <cosponsor name-id="E000291">Mrs. Ellmers</cosponsor>, <cosponsor name-id="M001180">Mr. McKinley</cosponsor>, <cosponsor name-id="H001045">Mr. Harper</cosponsor>, <cosponsor name-id="B001251">Mr. Butterfield</cosponsor>, <cosponsor name-id="C001097">Mr. Cárdenas</cosponsor>, <cosponsor name-id="L000570">Mr. Ben Ray Luján of New Mexico</cosponsor>, <cosponsor name-id="M001163">Ms. Matsui</cosponsor>, <cosponsor name-id="K000379">Mr. Kennedy</cosponsor>, <cosponsor name-id="L000565">Mr. Loebsack</cosponsor>, <cosponsor name-id="M001166">Mr. McNerney</cosponsor>, <cosponsor name-id="T000469">Mr. Tonko</cosponsor>, <cosponsor name-id="Y000062">Mr. Yarmuth</cosponsor>, <cosponsor name-id="A000369">Mr. Amodei</cosponsor>, <cosponsor name-id="F000372">Mr. Frelinghuysen</cosponsor>, <cosponsor name-id="H001056">Ms. Herrera Beutler</cosponsor>, <cosponsor name-id="J000295">Mr. Joyce</cosponsor>, <cosponsor name-id="S001192">Mr. Stewart</cosponsor>, <cosponsor name-id="H001034">Mr. Honda</cosponsor>, <cosponsor name-id="L000551">Ms. Lee</cosponsor>, <cosponsor name-id="R000486">Ms. Roybal-Allard</cosponsor>, <cosponsor name-id="K000009">Ms. Kaptur</cosponsor>, <cosponsor name-id="M001143">Ms. McCollum</cosponsor>, <cosponsor name-id="F000043">Mr. Fattah</cosponsor>, <cosponsor name-id="I000057">Mr. Israel</cosponsor>, <cosponsor name-id="P000597">Ms. Pingree</cosponsor>, <cosponsor name-id="R000576">Mr. Ruppersberger</cosponsor>, <cosponsor name-id="R000577">Mr. Ryan of Ohio</cosponsor>, <cosponsor name-id="W000804">Mr. Wittman</cosponsor>, <cosponsor name-id="K000210">Mr. King of New York</cosponsor>, <cosponsor name-id="S000244">Mr. Sensenbrenner</cosponsor>, <cosponsor name-id="D000533">Mr. Duncan of Tennessee</cosponsor>, <cosponsor name-id="H001048">Mr. Hunter</cosponsor>, <cosponsor name-id="P000258">Mr. Peterson</cosponsor>, <cosponsor name-id="H001038">Mr. Higgins</cosponsor>, <cosponsor name-id="P000604">Mr. Payne</cosponsor>, <cosponsor name-id="M000087">Mrs. Carolyn B. Maloney of New York</cosponsor>, <cosponsor name-id="C000714">Mr. Conyers</cosponsor>, <cosponsor name-id="D000191">Mr. DeFazio</cosponsor>, <cosponsor name-id="B000911">Ms. Brown of Florida</cosponsor>, <cosponsor name-id="C001072">Mr. Carson of Indiana</cosponsor>, <cosponsor name-id="C001101">Ms. Clark of Massachusetts</cosponsor>, <cosponsor name-id="D000620">Mr. Delaney</cosponsor>, <cosponsor name-id="E000293">Ms. Esty</cosponsor>, <cosponsor name-id="F000454">Mr. Foster</cosponsor>, <cosponsor name-id="P000592">Mr. Poe of Texas</cosponsor>, <cosponsor name-id="H001064">Mr. Heck of Washington</cosponsor>, <cosponsor name-id="H000636">Mr. Hinojosa</cosponsor>, <cosponsor name-id="J000288">Mr. Johnson of Georgia</cosponsor>, <cosponsor name-id="K000380">Mr. Kildee</cosponsor>, <cosponsor name-id="L000560">Mr. Larsen of Washington</cosponsor>, <cosponsor name-id="R000587">Mr. Ribble</cosponsor>, <cosponsor name-id="T000467">Mr. Thompson of Pennsylvania</cosponsor>, <cosponsor name-id="L000563">Mr. Lipinski</cosponsor>, <cosponsor name-id="L000562">Mr. Lynch</cosponsor>, <cosponsor name-id="M000312">Mr. McGovern</cosponsor>, <cosponsor name-id="P000607">Mr. Pocan</cosponsor>, <cosponsor name-id="P000598">Mr. Polis</cosponsor>, <cosponsor name-id="S001165">Mr. Sires</cosponsor>, <cosponsor name-id="F000460">Mr. Farenthold</cosponsor>, <cosponsor name-id="M001184">Mr. Massie</cosponsor>, <cosponsor name-id="B001285">Ms. Brownley of California</cosponsor>, <cosponsor name-id="B001286">Mrs. Bustos</cosponsor>, <cosponsor name-id="C001090">Mr. Cartwright</cosponsor>, <cosponsor name-id="P000599">Mr. Posey</cosponsor>, <cosponsor name-id="C001068">Mr. Cohen</cosponsor>, <cosponsor name-id="D000617">Ms. DelBene</cosponsor>, <cosponsor name-id="G000556">Mr. Grayson</cosponsor>, <cosponsor name-id="Y000033">Mr. Young of Alaska</cosponsor>, <cosponsor name-id="S000522">Mr. Smith of New Jersey</cosponsor>, <cosponsor name-id="B001278">Ms. Bonamici</cosponsor>, <cosponsor name-id="S001193">Mr. Swalwell of California</cosponsor>, <cosponsor name-id="T000465">Ms. Tsongas</cosponsor>, <cosponsor name-id="S001189">Mr. Austin Scott of Georgia</cosponsor>, <cosponsor name-id="G000553">Mr. Al Green of Texas</cosponsor>, <cosponsor name-id="H000324">Mr. Hastings</cosponsor>, <cosponsor name-id="L000559">Mr. Langevin</cosponsor>, <cosponsor name-id="L000579">Mr. Lowenthal</cosponsor>, <cosponsor name-id="N000179">Mrs. Napolitano</cosponsor>, <cosponsor name-id="N000147">Ms. Norton</cosponsor>, <cosponsor name-id="S001150">Mr. Schiff</cosponsor>, <cosponsor name-id="S001157">Mr. David Scott of Georgia</cosponsor>, <cosponsor name-id="T000472">Mr. Takano</cosponsor>, <cosponsor name-id="H001058">Mr. Huizenga of Michigan</cosponsor>, and <cosponsor name-id="H001068">Mr. Huffman</cosponsor>) introduced the following bill; which was referred to the <committee-name committee-id="HWM00">Committee on Ways and Means</committee-name></action-desc>
		</action>
		<legis-type>A BILL</legis-type>
		<official-title>To require the Commissioner of Social Security to revise the medical and evaluation criteria for
			 determining disability in a person diagnosed with Huntington’s Disease and
			 to waive the 24-month waiting period for Medicare eligibility for
			 individuals disabled by Huntington’s Disease.</official-title>
	</form>
	<legis-body id="HBBB4B9DE38054DE0B075E773291373D5" style="OLC">
 <section id="H506BBA3DBFC441AD82BFC8D72782A3AA" section-type="section-one"><enum>1.</enum><header>Short title</header><text display-inline="no-display-inline">This Act may be cited as the <quote><short-title>Huntington’s Disease Parity Act of 2015</short-title></quote>.</text> </section><section id="H87874FF21C6D41B98DC1C4BB6730E2DA"><enum>2.</enum><header>Findings</header><text display-inline="no-display-inline">Congress makes the following findings:</text>
 <paragraph id="H24486B6EEFC348AD814B3535EE34A6C0"><enum>(1)</enum><text>Huntington’s Disease is a progressive degenerative neurological disease that causes total physical and mental deterioration. In the United States, approximately 30,000 individuals are affected by Huntington’s Disease, along with another 200,000 individuals who are genetically <quote>at risk</quote>. There is no effective treatment in terms of halting or slowing the progression of the disease.</text>
 </paragraph><paragraph id="H3BF786AEB9AC453B94FED8DA3735493B"><enum>(2)</enum><text>Clinical indicators of Huntington’s Disease include—</text> <subparagraph id="H203B9ED603084591858BE91F852EF47F"><enum>(A)</enum><text>loss of ability to control bodily movements;</text>
 </subparagraph><subparagraph id="HF6A5CE7A1C664490944A057C59BA6BC3"><enum>(B)</enum><text>loss of ability to think or act quickly, inability to learn new material, and loss of memory; and</text> </subparagraph><subparagraph id="H6B3991580C1A484593D166CCD609F00E"><enum>(C)</enum><text>behavioral or psychological problems, including personality changes, irritability, mood swings, anxiety, obsessive-compulsive behavior, inability to concentrate, decreased motivation, and severe depression.</text>
 </subparagraph></paragraph><paragraph id="H42EB00C2A5CF4BD0A508DDB9CBD93BB8"><enum>(3)</enum><text>Adult-onset Huntington’s Disease typically results in the development of symptoms in individuals between 30 and 50 years of age. Late-onset Huntington’s Disease is characterized by development of symptoms after 50 years of age and is usually associated with a milder course of the disease. Juvenile Huntington’s Disease affects individuals who have yet to attain 19 years of age and progresses at a more rapid rate.</text>
 </paragraph><paragraph id="HFFF423DDFF9F480D8D3E0014F4BC4314"><enum>(4)</enum><text display-inline="yes-display-inline">Because of the incapacitating nature of Huntington’s Disease, individuals living with this illness, including those in the early stages of the disease, are unable to retain employment. As a result, many such individuals rely solely on Social Security Disability Insurance.</text>
 </paragraph><paragraph id="H1E11D5DDBE404814B0BE893B00006333"><enum>(5)</enum><text>Despite significant advances in medicine and a greater understanding of Huntington's Disease, the Social Security Administration has not comprehensively revised its rules for the medical evaluation of neurological disabilities since 1985. The designation of this disease by the Social Security Administration as <quote>Huntington’s Chorea</quote> is both outdated and medically inaccurate, as this term fails to recognize the behavioral and cognitive impact of Huntington's Disease, while also providing an incomplete characterization of the full spectrum of Huntington’s Disease for purposes of Social Security Disability Insurance and the Medicare program.</text>
 </paragraph><paragraph id="H81C829A8AD5542B384F2518709453706"><enum>(6)</enum><text>After qualifying for Social Security Disability Insurance, individuals with Huntington’s Disease must wait another 24 months before receiving benefits under the Medicare program, despite the fact that such individuals often become incapacitated before reaching the age-eligibility requirement under the Medicare program of 65 years of age.</text>
 </paragraph><paragraph id="H8C8748245A5D4B3FA670E0D92563320D"><enum>(7)</enum><text>In 2000, the Centers for Medicaid &amp; Medicare Services waived the 24-month waiting period requirement for people disabled by amyotrophic lateral sclerosis (<quote>ALS</quote>), a degenerative neurological condition that is similar to Huntington’s Disease.</text>
 </paragraph><paragraph id="HFED1B0DE29094CB79D677FC5946C4EC3"><enum>(8)</enum><text>In light of the outdated Social Security Disability Insurance guidelines for Huntington’s Disease and the significant cognitive, behavioral, and physical incapacitation faced by individuals with this disease, there is an urgent need for a revision of the medical and evaluation criteria used by the Social Security Administration in determining whether such individuals are disabled, as well as removal of the 24-month waiting period for coverage under the Medicare program for such individuals, similar to the existing exemption for individuals who have been diagnosed with ALS.</text>
			</paragraph></section><section id="HE93D487720834123AE3AABBA8D7F6B4D"><enum>3.</enum><header>Revision of medical and evaluation criteria for evaluating disability caused by adult-onset and
			 juvenile Huntington’s Disease</header>
 <subsection id="H146384CA761B40E68C4BE55B9BD2EA9A"><enum>(a)</enum><header>In general</header><text display-inline="yes-display-inline">For purposes of determinations of cognitive, behavioral, and physical disability under titles II and XVI of the Social Security Act, the Commissioner of Social Security, in consultation with the National Institute of Neurological Disorders and Stroke, the National Institutes of Health, and other relevant organizations with medical expertise relating to Adult-Onset and Juvenile Huntington’s Disease, shall, not later than 180 days after the date of the enactment of this Act—</text>
 <paragraph id="HAF16CA753EF24E49AC3F70DA87D06FF0"><enum>(1)</enum><text>amend section 11.00 of part A of the Listing of Impairments (relating to neurological impairments of adults) by—</text>
 <subparagraph id="H1EE6A00FE24A49DD9B93FE14C16C0183"><enum>(A)</enum><text>providing medical and evaluation criteria for Huntington’s Disease; and</text> </subparagraph><subparagraph id="H7E370DA2E14A4953846B1AEE7B43AA82"><enum>(B)</enum><text>striking <quote>Huntington’s Chorea</quote> each place it appears;</text>
 </subparagraph></paragraph><paragraph id="HAA9855F63E6347A88E1E27DE49777A09"><enum>(2)</enum><text>amend section 12.00 of part A of the Listing of Impairments (relating to mental disorders of adults) by providing medical and evaluation criteria for Huntington’s Disease;</text>
 </paragraph><paragraph id="HC5EA1677663348488BD4726A78271D2B"><enum>(3)</enum><text>amend section 111.00 of part B of the Listing of Impairments (relating to neurological impairments of children) by providing medical and evaluation criteria for Juvenile Huntington’s Disease; and</text>
 </paragraph><paragraph id="H30F805C77DE344C49235677334976684"><enum>(4)</enum><text>amend section 112.00 of part B of the Listing of Impairments (relating to mental disorders of children) by providing medical and evaluation criteria for Juvenile Huntington’s Disease.</text>
 </paragraph></subsection><subsection id="HB6EACB3B582545F684611B5F4A8FF3C6"><enum>(b)</enum><header>Listing of Impairments</header><text display-inline="yes-display-inline">For purposes of this section, the term <term>Listing of Impairments</term> means appendix 1 to subpart P of part 404 of title 20 of the Code of Federal Regulations.</text> </subsection></section><section id="H6D5D3AF313A14A68811A6C5CC0D077F8"><enum>4.</enum><header>Waiver of 24-month waiting period for coverage under Medicare program for individuals diagnosed with Huntington's Disease</header> <subsection id="H86135B6334414ACFBA91FF28D49491C1"><enum>(a)</enum><header>In General</header><text>Section 226(h) of the Social Security Act (<external-xref legal-doc="usc" parsable-cite="usc/42/426">42 U.S.C. 426(h)</external-xref>) is amended, in the matter preceding paragraph (1), by inserting <quote>or Huntington’s Disease (HD)</quote> after <quote>amyotrophic lateral sclerosis (ALS)</quote>.</text>
 </subsection><subsection id="H7B66790C86824284879A7D69DDA71126"><enum>(b)</enum><header>Effective Date</header><text>The amendment made by subsection (a) shall apply to benefits under title XVIII of the Social Security Act with respect to items and services furnished in months beginning after the date of the enactment of this Act.</text>
			</subsection></section></legis-body>
</bill>


